Rhonda Farnum
Patrimonio netto: 4 M $ in data 31/07/2026
Patrimonio netto: 4 M $ in data 31/07/2026
Ms. Rhonda F.
Farnum is a Chief Business Officer & SVP-Medical Affairs at Theravance Biopharma, Inc. Ms. Farnum was previously employed as a Head-Hematology Business Unit by Onyx Pharmaceuticals, Inc. She received her undergraduate degree from the University of Georgia.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/08/2026 | 226.790 ( 0,44% ) | 4 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Direttore Tecnico/Scientifico/R&S | - |
| Società | Posizione | Fine |
|---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/08/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale